Publicaciones en colaboración con investigadores/as de Oslo University Hospital (21)

2024

  1. Association between upper and lower respiratory disease among patients with primary ciliary dyskinesia: an international study

    ERJ Open Research, Vol. 10, Núm. 2

2023

  1. Characteristics of Otologic Disease Among Patients With Primary Ciliary Dyskinesia

    JAMA otolaryngology-- head & neck surgery, Vol. 149, Núm. 7, pp. 587-596

  2. Lack of Correlation of Sinonasal and Otologic Reported Symptoms With Objective Measurements Among Patients With Primary Ciliary Dyskinesia: An International Study

    Clinical and Experimental Otorhinolaryngology, Vol. 16, Núm. 4, pp. 407-412

  3. Sinonasal disease among patients with primary ciliary dyskinesia: An international study

    ERJ Open Research, Vol. 9, Núm. 3

2022

  1. Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

    Frontiers in Cell and Developmental Biology, Vol. 10

2021

  1. Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

    Frontiers in Cell and Developmental Biology, Vol. 9

  2. Frequency and prognostic impact of alk amplifications and mutations in the european neuroblastoma study group (siopen) high-risk neuroblastoma trial (hr-nbl1)

    Journal of Clinical Oncology, Vol. 39, Núm. 30, pp. 3377-3390

2020

  1. 11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

    Cell Reports, Vol. 32, Núm. 12

  2. Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report from the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

    Journal of Clinical Oncology, Vol. 38, Núm. 31, pp. 3685-3697

2018

  1. Heterogeneous MYCN amplification in neuroblastoma: A SIOP Europe Neuroblastoma Study

    British Journal of Cancer, Vol. 118, Núm. 11, pp. 1502-1512

2016

  1. N-Acetylcysteine Amide Exerts Possible Neuroprotective Effects in Newborn Pigs after Perinatal Asphyxia

    Neonatology, Vol. 111, Núm. 1, pp. 12-21

2015

  1. Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 290-295

2013

  1. Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee

    Pediatric Blood and Cancer, Vol. 60, Núm. 3, pp. 363-370

  2. Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN study

    European Journal of Cancer, Vol. 49, Núm. 17, pp. 3671-3679

2012

  1. Segmental chromosomal alterations have prognostic impact in neuroblastoma: A report from the INRG project

    British Journal of Cancer, Vol. 107, Núm. 8, pp. 1418-1422

2011

  1. A multilocus technique for risk evaluation of patients with neuroblastoma

    Clinical Cancer Research, Vol. 17, Núm. 4, pp. 792-804

  2. Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

    British Journal of Cancer, Vol. 105, Núm. 12, pp. 1940-1948

2010

  1. A tissue microarray study of osteosarcoma: Histopathologic and immunohistochemical validation of xenotransplanted tumors as preclinical models

    Applied Immunohistochemistry and Molecular Morphology, Vol. 18, Núm. 5, pp. 453-461

  2. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

    Clinical Cancer Research, Vol. 16, Núm. 17, pp. 4353-4362

  3. Triple-negative breast cancer: Present challenges and new perspectives

    Molecular Oncology, Vol. 4, Núm. 3, pp. 209-229